These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 38992201)
1. Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis. Li L; Xiao F; Wang S; Kuang S; Li Z; Zhong Y; Xu D; Cai Y; Li S; Chen J; Liu Y; Li J; Li H; Xu H Sci Rep; 2024 Jul; 14(1):16031. PubMed ID: 38992201 [TBL] [Abstract][Full Text] [Related]
2. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study. Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594 [TBL] [Abstract][Full Text] [Related]
3. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma. Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505 [TBL] [Abstract][Full Text] [Related]
4. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma. Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive O Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292 [TBL] [Abstract][Full Text] [Related]
6. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219 [TBL] [Abstract][Full Text] [Related]
7. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas. Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598 [TBL] [Abstract][Full Text] [Related]
8. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis. Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012 [TBL] [Abstract][Full Text] [Related]
9. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach. Do DT; Yang MR; Lam LHT; Le NQK; Wu YW Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323 [TBL] [Abstract][Full Text] [Related]
10. Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach. Crisi G; Filice S J Neuroimaging; 2020 Jul; 30(4):458-462. PubMed ID: 32374045 [TBL] [Abstract][Full Text] [Related]
11. Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864 [TBL] [Abstract][Full Text] [Related]
12. Development of A Radiomic Model for Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308 [TBL] [Abstract][Full Text] [Related]
13. Radiomics for predicting MGMT status in cerebral glioblastoma: comparison of different MRI sequences. Zheng F; Zhang L; Chen H; Zang Y; Chen X; Li Y J Radiat Res; 2024 May; 65(3):350-359. PubMed ID: 38650477 [TBL] [Abstract][Full Text] [Related]
14. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics. Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914 [TBL] [Abstract][Full Text] [Related]
15. The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated Choi YS; Ahn SS; Lee HJ; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK AJNR Am J Neuroradiol; 2017 Aug; 38(8):1528-1535. PubMed ID: 28642265 [TBL] [Abstract][Full Text] [Related]
16. Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation. Yoon RG; Kim HS; Paik W; Shim WH; Kim SJ; Kim JH Eur Radiol; 2017 Jan; 27(1):255-266. PubMed ID: 27048531 [TBL] [Abstract][Full Text] [Related]
17. Adaptive fine-tuning based transfer learning for the identification of MGMT promoter methylation status. Schmitz E; Guo Y; Wang J Biomed Phys Eng Express; 2024 Jul; 10(5):. PubMed ID: 39029475 [No Abstract] [Full Text] [Related]
18. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas. Korfiatis P; Kline TL; Coufalova L; Lachance DH; Parney IF; Carter RE; Buckner JC; Erickson BJ Med Phys; 2016 Jun; 43(6):2835-2844. PubMed ID: 27277032 [TBL] [Abstract][Full Text] [Related]
19. Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis. Doniselli FM; Pascuzzo R; Mazzi F; Padelli F; Moscatelli M; Akinci D'Antonoli T; Cuocolo R; Aquino D; Cuccarini V; Sconfienza LM Eur Radiol; 2024 Sep; 34(9):5802-5815. PubMed ID: 38308012 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma. Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]